Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Ondo Insurtech Plc is a company specializing in developing cutting-edge technology solutions for the insurance industry. Ondo Insurtech's primary function is to enhance the efficiency and efficacy of insurance operations through its innovative platforms, which integrate artificial intelligence and data-driven insights. The company provides an array of products aimed at streamlining claims management, underwriting processes, and customer engagement for insurance providers. Ondo Insurtech is notable for its focus on modernizing traditional insurance practices by applying digital transformation strategies. This effort impacts various segments of the insurance market, including property, casualty, health, and life insurance sectors. By leveraging technology, the company aids insurance firms in improving risk assessment, lowering operational costs, and enhancing customer satisfaction. In the financial market, Ondo Insurtech plays a critical role as an enabler of change within the insurance industry, helping insurers adapt to the evolving technological landscape. It contributes to driving innovation and competitiveness within the sector, making it a significant player in the ongoing digital evolution in financial services. Ondo Insurtech's developments are vital as they support the insurance sector's push towards more automated and personalized service offerings.
£0.07
£0.00 (-3.65%)
EOD Jul 3, 2026
The business is unprofitable at the operating level (-133.83% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 43.8%, still solid. Margins contracted 13.7pp, which offsets some of the top-line progress.
Negative free cash flow of -£4M. The business is consuming cash, not generating it. Operating margin contracted 13.7pp YoY, cost discipline may be slipping.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£4M
▲ +43.8% YoY
Net Income (TTM)
-£6M
▼ -106.3% YoY
Op. Margin
-133.83%
▼ -13.7pp YoY
ROIC
-60.34%
▲ +2.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-£4M
▼ -35.0% YoY
Op. Cash Flow (TTM)
-£4M
▼ -34.5% YoY
Net Debt
£3M
Cash & Equiv.
£4M
Continue Research
Ondo Insurtech (ONDO.XLON)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Ondo Insurtech scores 0/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Ondo Insurtech scores 0 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -133.8% operating margin and a -60.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh ONDO.XLON's valuation and scores 0/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.